Oral Contraceptive-United States Market Status and Trend Report 2013-2023
Report Summary
Oral Contraceptive-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Oral Contraceptive industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Oral Contraceptive 2013-2017, and development forecast 2018-2023
Main market players of Oral Contraceptive in United States, with company and product introduction, position in the Oral Contraceptive market
Market status and development trend of Oral Contraceptive by types and applications
Cost and profit status of Oral Contraceptive, and marketing status
Market growth drivers and challenges
The report segments the United States Oral Contraceptive market as:
United States Oral Contraceptive Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Oral Contraceptive Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Combination
Progestin Only
Others
United States Oral Contraceptive Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Male
Female
United States Oral Contraceptive Market: Players Segment Analysis (Company and Product introduction, Oral Contraceptive Sales Volume, Revenue, Price and Gross Margin):
Pfizer, Inc.
Bayer AG
Merck & Co., Inc.
Janssen Global Services, LLC
Mankind Pharma Ltd.
Teva Pharmaceutical Industries Ltd
Allergan, plc (Actavis)
Piramal Enterprises Ltd.
Beijing Zizhu Pharm
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Oral Contraceptive-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Oral Contraceptive industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Oral Contraceptive 2013-2017, and development forecast 2018-2023
Main market players of Oral Contraceptive in United States, with company and product introduction, position in the Oral Contraceptive market
Market status and development trend of Oral Contraceptive by types and applications
Cost and profit status of Oral Contraceptive, and marketing status
Market growth drivers and challenges
The report segments the United States Oral Contraceptive market as:
United States Oral Contraceptive Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Oral Contraceptive Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Combination
Progestin Only
Others
United States Oral Contraceptive Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Male
Female
United States Oral Contraceptive Market: Players Segment Analysis (Company and Product introduction, Oral Contraceptive Sales Volume, Revenue, Price and Gross Margin):
Pfizer, Inc.
Bayer AG
Merck & Co., Inc.
Janssen Global Services, LLC
Mankind Pharma Ltd.
Teva Pharmaceutical Industries Ltd
Allergan, plc (Actavis)
Piramal Enterprises Ltd.
Beijing Zizhu Pharm
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ORAL CONTRACEPTIVE
1.1 Definition of Oral Contraceptive in This Report
1.2 Commercial Types of Oral Contraceptive
1.2.1 Combination
1.2.2 Progestin Only
1.2.3 Others
1.3 Downstream Application of Oral Contraceptive
1.3.1 Male
1.3.2 Female
1.4 Development History of Oral Contraceptive
1.5 Market Status and Trend of Oral Contraceptive 2013-2023
1.5.1 United States Oral Contraceptive Market Status and Trend 2013-2023
1.5.2 Regional Oral Contraceptive Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Oral Contraceptive in United States 2013-2017
2.2 Consumption Market of Oral Contraceptive in United States by Regions
2.2.1 Consumption Volume of Oral Contraceptive in United States by Regions
2.2.2 Revenue of Oral Contraceptive in United States by Regions
2.3 Market Analysis of Oral Contraceptive in United States by Regions
2.3.1 Market Analysis of Oral Contraceptive in New England 2013-2017
2.3.2 Market Analysis of Oral Contraceptive in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Oral Contraceptive in The Midwest 2013-2017
2.3.4 Market Analysis of Oral Contraceptive in The West 2013-2017
2.3.5 Market Analysis of Oral Contraceptive in The South 2013-2017
2.3.6 Market Analysis of Oral Contraceptive in Southwest 2013-2017
2.4 Market Development Forecast of Oral Contraceptive in United States 2018-2023
2.4.1 Market Development Forecast of Oral Contraceptive in United States 2018-2023
2.4.2 Market Development Forecast of Oral Contraceptive by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Oral Contraceptive in United States by Types
3.1.2 Revenue of Oral Contraceptive in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Oral Contraceptive in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Oral Contraceptive in United States by Downstream Industry
4.2 Demand Volume of Oral Contraceptive by Downstream Industry in Major Countries
4.2.1 Demand Volume of Oral Contraceptive by Downstream Industry in New England
4.2.2 Demand Volume of Oral Contraceptive by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Oral Contraceptive by Downstream Industry in The Midwest
4.2.4 Demand Volume of Oral Contraceptive by Downstream Industry in The West
4.2.5 Demand Volume of Oral Contraceptive by Downstream Industry in The South
4.2.6 Demand Volume of Oral Contraceptive by Downstream Industry in Southwest
4.3 Market Forecast of Oral Contraceptive in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ORAL CONTRACEPTIVE
5.1 United States Economy Situation and Trend Overview
5.2 Oral Contraceptive Downstream Industry Situation and Trend Overview
CHAPTER 6 ORAL CONTRACEPTIVE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Oral Contraceptive in United States by Major Players
6.2 Revenue of Oral Contraceptive in United States by Major Players
6.3 Basic Information of Oral Contraceptive by Major Players
6.3.1 Headquarters Location and Established Time of Oral Contraceptive Major Players
6.3.2 Employees and Revenue Level of Oral Contraceptive Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ORAL CONTRACEPTIVE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Pfizer, Inc.
7.1.1 Company profile
7.1.2 Representative Oral Contraceptive Product
7.1.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Pfizer, Inc.
7.2 Bayer AG
7.2.1 Company profile
7.2.2 Representative Oral Contraceptive Product
7.2.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Bayer AG
7.3 Merck & Co., Inc.
7.3.1 Company profile
7.3.2 Representative Oral Contraceptive Product
7.3.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Merck & Co., Inc.
7.4 Janssen Global Services, LLC
7.4.1 Company profile
7.4.2 Representative Oral Contraceptive Product
7.4.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Janssen Global Services, LLC
7.5 Mankind Pharma Ltd.
7.5.1 Company profile
7.5.2 Representative Oral Contraceptive Product
7.5.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Mankind Pharma Ltd.
7.6 Teva Pharmaceutical Industries Ltd
7.6.1 Company profile
7.6.2 Representative Oral Contraceptive Product
7.6.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical Industries Ltd
7.7 Allergan, plc (Actavis)
7.7.1 Company profile
7.7.2 Representative Oral Contraceptive Product
7.7.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Allergan, plc (Actavis)
7.8 Piramal Enterprises Ltd.
7.8.1 Company profile
7.8.2 Representative Oral Contraceptive Product
7.8.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Piramal Enterprises Ltd.
7.9 Beijing Zizhu Pharm
7.9.1 Company profile
7.9.2 Representative Oral Contraceptive Product
7.9.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Beijing Zizhu Pharm
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ORAL CONTRACEPTIVE
8.1 Industry Chain of Oral Contraceptive
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ORAL CONTRACEPTIVE
9.1 Cost Structure Analysis of Oral Contraceptive
9.2 Raw Materials Cost Analysis of Oral Contraceptive
9.3 Labor Cost Analysis of Oral Contraceptive
9.4 Manufacturing Expenses Analysis of Oral Contraceptive
CHAPTER 10 MARKETING STATUS ANALYSIS OF ORAL CONTRACEPTIVE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Oral Contraceptive in This Report
1.2 Commercial Types of Oral Contraceptive
1.2.1 Combination
1.2.2 Progestin Only
1.2.3 Others
1.3 Downstream Application of Oral Contraceptive
1.3.1 Male
1.3.2 Female
1.4 Development History of Oral Contraceptive
1.5 Market Status and Trend of Oral Contraceptive 2013-2023
1.5.1 United States Oral Contraceptive Market Status and Trend 2013-2023
1.5.2 Regional Oral Contraceptive Market Status and Trend 2013-2023
CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Oral Contraceptive in United States 2013-2017
2.2 Consumption Market of Oral Contraceptive in United States by Regions
2.2.1 Consumption Volume of Oral Contraceptive in United States by Regions
2.2.2 Revenue of Oral Contraceptive in United States by Regions
2.3 Market Analysis of Oral Contraceptive in United States by Regions
2.3.1 Market Analysis of Oral Contraceptive in New England 2013-2017
2.3.2 Market Analysis of Oral Contraceptive in The Middle Atlantic 2013-2017
2.3.3 Market Analysis of Oral Contraceptive in The Midwest 2013-2017
2.3.4 Market Analysis of Oral Contraceptive in The West 2013-2017
2.3.5 Market Analysis of Oral Contraceptive in The South 2013-2017
2.3.6 Market Analysis of Oral Contraceptive in Southwest 2013-2017
2.4 Market Development Forecast of Oral Contraceptive in United States 2018-2023
2.4.1 Market Development Forecast of Oral Contraceptive in United States 2018-2023
2.4.2 Market Development Forecast of Oral Contraceptive by Regions 2018-2023
CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES
3.1 Whole United States Market Status by Types
3.1.1 Consumption Volume of Oral Contraceptive in United States by Types
3.1.2 Revenue of Oral Contraceptive in United States by Types
3.2 United States Market Status by Types in Major Countries
3.2.1 Market Status by Types in New England
3.2.2 Market Status by Types in The Middle Atlantic
3.2.3 Market Status by Types in The Midwest
3.2.4 Market Status by Types in The West
3.2.5 Market Status by Types in The South
3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Oral Contraceptive in United States by Types
CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Oral Contraceptive in United States by Downstream Industry
4.2 Demand Volume of Oral Contraceptive by Downstream Industry in Major Countries
4.2.1 Demand Volume of Oral Contraceptive by Downstream Industry in New England
4.2.2 Demand Volume of Oral Contraceptive by Downstream Industry in The Middle Atlantic
4.2.3 Demand Volume of Oral Contraceptive by Downstream Industry in The Midwest
4.2.4 Demand Volume of Oral Contraceptive by Downstream Industry in The West
4.2.5 Demand Volume of Oral Contraceptive by Downstream Industry in The South
4.2.6 Demand Volume of Oral Contraceptive by Downstream Industry in Southwest
4.3 Market Forecast of Oral Contraceptive in United States by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ORAL CONTRACEPTIVE
5.1 United States Economy Situation and Trend Overview
5.2 Oral Contraceptive Downstream Industry Situation and Trend Overview
CHAPTER 6 ORAL CONTRACEPTIVE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES
6.1 Sales Volume of Oral Contraceptive in United States by Major Players
6.2 Revenue of Oral Contraceptive in United States by Major Players
6.3 Basic Information of Oral Contraceptive by Major Players
6.3.1 Headquarters Location and Established Time of Oral Contraceptive Major Players
6.3.2 Employees and Revenue Level of Oral Contraceptive Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ORAL CONTRACEPTIVE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Pfizer, Inc.
7.1.1 Company profile
7.1.2 Representative Oral Contraceptive Product
7.1.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Pfizer, Inc.
7.2 Bayer AG
7.2.1 Company profile
7.2.2 Representative Oral Contraceptive Product
7.2.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Bayer AG
7.3 Merck & Co., Inc.
7.3.1 Company profile
7.3.2 Representative Oral Contraceptive Product
7.3.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Merck & Co., Inc.
7.4 Janssen Global Services, LLC
7.4.1 Company profile
7.4.2 Representative Oral Contraceptive Product
7.4.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Janssen Global Services, LLC
7.5 Mankind Pharma Ltd.
7.5.1 Company profile
7.5.2 Representative Oral Contraceptive Product
7.5.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Mankind Pharma Ltd.
7.6 Teva Pharmaceutical Industries Ltd
7.6.1 Company profile
7.6.2 Representative Oral Contraceptive Product
7.6.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Teva Pharmaceutical Industries Ltd
7.7 Allergan, plc (Actavis)
7.7.1 Company profile
7.7.2 Representative Oral Contraceptive Product
7.7.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Allergan, plc (Actavis)
7.8 Piramal Enterprises Ltd.
7.8.1 Company profile
7.8.2 Representative Oral Contraceptive Product
7.8.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Piramal Enterprises Ltd.
7.9 Beijing Zizhu Pharm
7.9.1 Company profile
7.9.2 Representative Oral Contraceptive Product
7.9.3 Oral Contraceptive Sales, Revenue, Price and Gross Margin of Beijing Zizhu Pharm
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ORAL CONTRACEPTIVE
8.1 Industry Chain of Oral Contraceptive
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ORAL CONTRACEPTIVE
9.1 Cost Structure Analysis of Oral Contraceptive
9.2 Raw Materials Cost Analysis of Oral Contraceptive
9.3 Labor Cost Analysis of Oral Contraceptive
9.4 Manufacturing Expenses Analysis of Oral Contraceptive
CHAPTER 10 MARKETING STATUS ANALYSIS OF ORAL CONTRACEPTIVE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
